Literature DB >> 30226191

Galectin-3 aggravates experimental polymicrobial sepsis by impairing neutrophil recruitment to the infectious focus.

Raphael G Ferreira1, Lilian C Rodrigues2, Daniele C Nascimento1, Alexandre Kanashiro1, Paulo H Melo1, Vanessa F Borges1, Aline Gozzi3, Douglas da Silva Prado1, Marcos C Borges3, Fernando S Ramalho4, Sean R Stowell5, Richard D Cummings6, Marcelo Dias-Baruffi2, Fernando Q Cunha1, Jose C Alves-Filho7.   

Abstract

Sepsis is an overwhelming systemic inflammation resulting from an uncontrolled infection that causes extensive tissue damage, organ dysfunction and eventually death. A growing body of evidence indicates that impaired neutrophil migration to the site of infection is associated with poor outcome in sepsis. Here we show that galectin-3 (Gal-3), an endogenous glycan-binding protein, plays a critical role in sepsis outcome. We found that serum Gal-3 concentration increased in patients with septic shock and mice undergoing sepsis induced by cecal ligation and puncture (CLP). Mice deficient in Gal-3 (Gal-3 KO) are more resistant to sepsis induced by CLP, showing lower levels of biochemical markers and neutrophil infiltration for organ injury/dysfunction than those observed in wild-type mice (WT). Furthermore, Gal-3 KO mice show an increased number of neutrophils in the primary focus of infection and reduced bacterial loads in the peritoneal cavity, blood, and lungs. Mechanistically, blood neutrophils from septic mice show higher levels of surface-bound Gal-3 than neutrophils from naive mice. The deficiency of Gal-3 was associated with increased rolling and adhesion of these cells in mesenteric venules. Our results indicate that Gal-3, secreted during sepsis, inhibits neutrophil migration into the infectious focus, which promotes the bacterial spread and worsens the outcome of sepsis.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Keywords:  CLP; Galectin-3; Neutrophil; Sepsis

Mesh:

Substances:

Year:  2018        PMID: 30226191     DOI: 10.1016/j.jinf.2018.06.010

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  6 in total

Review 1.  The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function.

Authors:  Brian S Robinson; Connie M Arthur; Birk Evavold; Ethan Roback; Nourine A Kamili; Caleb S Stowell; Mary L Vallecillo-Zúniga; Pam M Van Ry; Marcelo Dias-Baruffi; Richard D Cummings; Sean R Stowell
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 8.786

Review 2.  Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target.

Authors:  Livia Salmi; Francesco Gavelli; Filippo Patrucco; Marina Caputo; Gian Carlo Avanzi; Luigi Mario Castello
Journal:  Dis Markers       Date:  2019-08-14       Impact factor: 3.434

3.  Galectin-3 in septic acute kidney injury: a translational study.

Authors:  Haibing Sun; Huiping Jiang; Amity Eliaz; John A Kellum; Zhiyong Peng; Isaac Eliaz
Journal:  Crit Care       Date:  2021-03-18       Impact factor: 9.097

4.  Gal3 Plays a Deleterious Role in a Mouse Model of Endotoxemia.

Authors:  Juan Carlos Fernández-Martín; Ana María Espinosa-Oliva; Irene García-Domínguez; Isaac Rosado-Sánchez; Yolanda M Pacheco; Rosario Moyano; José G Monterde; José Luis Venero; Rocío M de Pablos
Journal:  Int J Mol Sci       Date:  2022-01-21       Impact factor: 5.923

5.  Galectin-3 regulates proinflammatory cytokine function and favours Brucella abortus chronic replication in macrophages and mice.

Authors:  Fernanda L Tana; Erika S Guimarães; Daiane M Cerqueira; Priscila C Campos; Marco Túlio R Gomes; Fábio V Marinho; Sergio C Oliveira
Journal:  Cell Microbiol       Date:  2021-07-02       Impact factor: 4.115

6.  Transcriptomic responses from improved murine sepsis models can better mimic human surgical sepsis.

Authors:  Philip A Efron; Dijoia B Darden; Zhongkai Wang; Dina C Nacionales; Maria-Cecilia Lopez; Russell B Hawkins; Michael C Cox; Jaimar C Rincon; Ricardo Ungaro; Marvin L Dirain; Gabriela L Ghita; Tianmeng Chen; Timothy R Billiar; Matthew J Delano; Christiaan Leeuwenburgh; Azra Bihorac; Scott C Brakenridge; Frederick A Moore; Alicia M Mohr; Ronald G Tompkins; Babette A Brumback; Henry V Baker; Gilbert R Upchurch; Lyle L Moldawer
Journal:  FASEB J       Date:  2020-11-02       Impact factor: 5.834

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.